Top in ID: Indoor mask guidance, COVID-19 vaccine authorization in adolescents
Click Here to Manage Email Alerts
The CDC’s announcement that it was relaxing indoor mask guidance for people who are fully vaccinated was the top story in infectious disease last week.
Another top story was the FDA authorization of the Pfizer-BioNTech vaccine among children aged 12 to 15 years. The companies formally asked the FDA last month to expand the authorization based on phase 3 data showing that the vaccine is safe and effective in adolescents.
Read these and more top stories in infectious disease below:
‘We have longed for this moment’: CDC relaxes indoor mask guidance
Fully vaccinated Americans no longer need to wear masks or socially distance indoors, the CDC said Thursday in updated guidance. Read more.
FDA authorizes Pfizer-BioNTech vaccine in children aged 12 to 15 years
The FDA authorized the use of the Pfizer-BioNTech COVID-19 vaccine in children aged 12 to 15 years. The vaccine, which was previously available for people aged 16 years or older, remains the only COVID-19 shot available for any pediatric population. Read more.
Q&A: AAP endorses giving routine immunizations, COVID-19 vaccines at same time
The AAP has endorsed giving childhood and adolescent immunizations at the same time as COVID-19 vaccines. Read more.
Q&A: CDC mask guidance ‘still too cautious and too complicated’
As the COVID-19 vaccine rollout continues, the CDC has continued to update its mask guidance for the public, recently revising recommendations for outdoor mask use and children’s summer and overnight camps. Read more.
Q&A: ‘Structural changes’ to health care systems needed to support COVID-19 ‘long-haulers’
To support patients with so-called “long-haulers,” Lekshmi Santhosh, MD, MAEd, assistant professor of medicine at the University of California, San Francisco, and colleagues founded the Post-COVID/Post-ICU Multidisciplinary Clinic, which they call the OPTIMAL Clinic. Healio spoke with Santhosh about the role of the clinic and the current state of research regarding COVID-19 long-haulers. Read more.